These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11589064)

  • 1. Clinical trials referral resource. Current clinical trials of epothilone B analog (BMS-247550).
    Colevas AD; West PJ; Cheson BD
    Oncology (Williston Park); 2001 Sep; 15(9):1168-9, 1172-5. PubMed ID: 11589064
    [No Abstract]   [Full Text] [Related]  

  • 2. BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy.
    Lee FY; Borzilleri R; Fairchild CR; Kim SH; Long BH; Reventos-Suarez C; Vite GD; Rose WC; Kramer RA
    Clin Cancer Res; 2001 May; 7(5):1429-37. PubMed ID: 11350914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epothilone D (Kosan/Roche).
    Kolman A
    Curr Opin Investig Drugs; 2004 Jun; 5(6):657-67. PubMed ID: 15242255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BMS-310705 Bristol-Myers Squibb/GBF.
    Kolman A
    Curr Opin Investig Drugs; 2004 Dec; 5(12):1292-7. PubMed ID: 15648951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trials referral resource. Current clinical trials of fenretinide.
    Swerdlow RD; Zwiebel JA; Gravell AE; Cheson BD
    Oncology (Williston Park); 2001 Dec; 15(12):1595-6, 1598, 1600. PubMed ID: 11780702
    [No Abstract]   [Full Text] [Related]  

  • 6. Epothilones: clinical update and future directions.
    Donovan D; Vahdat LT
    Oncology (Williston Park); 2008 Apr; 22(4):408-16; discussion 416, 421, 424 passim. PubMed ID: 18472615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy and safety of ixabepilone (BMS-247550), a novel epothilone B analogue].
    Villanueva C; Dufresne A; Pivot X; Viel E
    Bull Cancer; 2008 Feb; 95(2):197-204. PubMed ID: 18304905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical synthesis and biological properties of pyridine epothilones.
    Nicolaou KC; Scarpelli R; Bollbuck B; Werschkun B; Pereira MM; Wartmann M; Altmann KH; Zaharevitz D; Gussio R; Giannakakou P
    Chem Biol; 2000 Aug; 7(8):593-9. PubMed ID: 11048950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trials referral resource. Current clinical trials for the proteasome inhibitor PS-341.
    Wright J; Hillsamer VL; Gore-Langton RE; Cheson BD
    Oncology (Williston Park); 2000 Nov; 14(11):1589-90, 1593-4, 1597. PubMed ID: 11125942
    [No Abstract]   [Full Text] [Related]  

  • 10. EPO-906 (Novartis).
    Galmarini CM; Dumontet C
    IDrugs; 2003 Dec; 6(12):1182-7. PubMed ID: 14666430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of epothilones A and B in solid and solution phase.
    Nicolaou KC; Winssinger N; Pastor J; Ninkovic S; Sarabia F; He Y; Vourloumis D; Yang Z; Li T; Giannakakou P; Hamel E
    Nature; 1997 May; 387(6630):268-72. PubMed ID: 9153390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the microtubules in breast cancer beyond taxanes: the epothilones.
    Cortes J; Baselga J
    Oncologist; 2007 Mar; 12(3):271-80. PubMed ID: 17405891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total synthesis of 16-desmethylepothilone B, epothilone B10, epothilone F, and related side chain modified epothilone B analogues.
    Nicolaou KC; Hepworth D; King NP; Finlay MR; Scarpelli R; Pereira MM; Bollbuck B; Bigot A; Werschkun B; Winssinger N
    Chemistry; 2000 Aug; 6(15):2783-800. PubMed ID: 10985727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SNS-595, a naphthyridine cell cycle inhibitor and stimulator of apoptosis for the treatment of cancers.
    Mills DA; Fekrazad HM; Verschraegen CF
    Curr Opin Investig Drugs; 2008 Jun; 9(6):647-57. PubMed ID: 18516764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epothilones and related structures--a new class of microtubule inhibitors with potent in vivo antitumor activity.
    Altmann KH; Wartmann M; O'Reilly T
    Biochim Biophys Acta; 2000 May; 1470(3):M79-91. PubMed ID: 10799747
    [No Abstract]   [Full Text] [Related]  

  • 16. Epothilone B stabilizes microtubuli of macrophages like taxol without showing taxol-like endotoxin activity.
    Muhlradt PF; Sasse F
    Cancer Res; 1997 Aug; 57(16):3344-6. PubMed ID: 9269992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical discovery of ixabepilone, a highly active antineoplastic agent.
    Lee FY; Borzilleri R; Fairchild CR; Kamath A; Smykla R; Kramer R; Vite G
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):157-66. PubMed ID: 18347795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the interactivity of complex synthesis and tumor pharmacology in the drug discovery process: total synthesis and comparative in vivo evaluations of the 15-aza epothilones.
    Stachel SJ; Lee CB; Spassova M; Chappell MD; Bornmann WG; Danishefsky SJ; Chou TC; Guan Y
    J Org Chem; 2001 Jun; 66(12):4369-78. PubMed ID: 11397179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derivatization of the C12-C13 functional groups of epothilones A, B and C.
    Sefkow M; Kiffe M; Höfle G
    Bioorg Med Chem Lett; 1998 Nov; 8(21):3031-6. PubMed ID: 9873670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo metabolism of epothilone B in tumor-bearing nude mice: identification of three new epothilone B metabolites by capillary high-pressure liquid chromatography/mass spectrometry/tandem mass spectrometry.
    Blum W; Aichholz R; Ramstein P; Kühnöl J; Brüggen J; O'Reilly T; Flörsheimer A
    Rapid Commun Mass Spectrom; 2001; 15(1):41-9. PubMed ID: 11135423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.